Skip to content
Open in App
Alcon logo

Alcon

web2

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwi...

Symbol · 1ALC
Company profile

About

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company’s cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Explore by sector

Explore this sector

Market identity

Exchange listings

Listing identities only. Orbitrum does not publish live prices or market performance on this public profile.

Progress

Roadmap

Discontinue the PowerVision IOL programs

KEY STEP

Alcon announced that it discontinued the PowerVision intraocular lens programs after reviewing clinical study data that showed persistent unpredictable postoperative visual outcomes in a subset of patients despite multiple development efforts.

Roadmap reference
People

Company team

SH

Scott Harlan Maw

Independent Director

Company leadership profile.

FM

F. Michael Ball

Independent Chairman

Company leadership profile.

DJ

David J. Endicott

CEO & Director

Company leadership profile.

DK

D. Keith Grossman

Independent Vice Chair

Company leadership profile.

KJ

Karen J. May

Independent Director

Company leadership profile.

RS

Richard Scott Herren

Independent Director

Company leadership profile.

LD

Lynn Dorsey Bleil

Independent Director

Company leadership profile.

AB

Arthur B. Cummings

Independent Director

Company leadership profile.

TH

Thomas H. Glanzmann

Independent Director

Company leadership profile.

IP

Ines Poeschel

Independent Director

Company leadership profile.

DS

Dieter Spälti

Independent Director

Company leadership profile.

DD

Deborah DiSanzo Eldracher

Independent Director

Company leadership profile.

Expert coverage

1 expert evaluated Alcon.

Orbitrum research

Experts evaluating Alcon

Explore the public profiles of experts who have evaluated this project.

Orbitrum Academy

Learn how to read a project assessment